WO1997017105A1 - Needle myolysis system for uterine fibroids - Google Patents

Needle myolysis system for uterine fibroids Download PDF

Info

Publication number
WO1997017105A1
WO1997017105A1 PCT/US1996/017923 US9617923W WO9717105A1 WO 1997017105 A1 WO1997017105 A1 WO 1997017105A1 US 9617923 W US9617923 W US 9617923W WO 9717105 A1 WO9717105 A1 WO 9717105A1
Authority
WO
WIPO (PCT)
Prior art keywords
needle
distal end
sheath
electrosurgical
target tissue
Prior art date
Application number
PCT/US1996/017923
Other languages
French (fr)
Inventor
George M. Savage
Margaret Webber
Original Assignee
Femrx, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Femrx, Inc. filed Critical Femrx, Inc.
Publication of WO1997017105A1 publication Critical patent/WO1997017105A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1477—Needle-like probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1482—Probes or electrodes therefor having a long rigid shaft for accessing the inner body transcutaneously in minimal invasive surgery, e.g. laparoscopy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1485—Probes or electrodes therefor having a short rigid shaft for accessing the inner body through natural openings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017—Electrical control of surgical instruments
    • A61B2017/00022—Sensing or detecting at the treatment site
    • A61B2017/00084—Temperature
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017—Electrical control of surgical instruments
    • A61B2017/00022—Sensing or detecting at the treatment site
    • A61B2017/00106—Sensing or detecting at the treatment site ultrasonic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053—Mechanical features of the instrument of device
    • A61B2018/00184—Moving parts
    • A61B2018/00196—Moving parts reciprocating lengthwise
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206—Generators therefor
    • A61B2018/1246—Generators therefor characterised by the output polarity
    • A61B2018/1253—Generators therefor characterised by the output polarity monopolar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36—Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37—Surgical systems with images on a monitor during operation
    • A61B2090/378—Surgical systems with images on a monitor during operation using ultrasound
    • A61B2090/3782—Surgical systems with images on a monitor during operation using ultrasound transmitter or receiver in catheter or minimal invasive instrument

Definitions

  • Benign leiorayomata are common tumors which affect more than 25% of all women at some time during the reproductive years. Many women wish to have fibroid-related symptoms such as bleeding and pain treated without resort to hysterectomy. Pharmacologic therapy alone is of limited utility due to side-effects associated with long-term use. Hysteroscopic resection using the loop or vaporizing resectoscope is appropriate for those tumors which protrude into the uterine cavity--so called submucous myomas. Surgical myomectomy (removal of the fibroid) is often used for tumors which are thought to be the cause of infertility. However, this approach usually requires a laparotomy and is often associated with adhesion formation between the uterus, bowel and other adjacent structures. These adhesions can be the cause of chronic pain in some patients.
  • Needle myolysis is a promising technique whereby a laparoscope is used to introduce one or more needles into a fibroid t umor under visual control. Bipolar Radio Frequency ("RF") current is then delivered between two adjacent needles, or unipolar current between a single needle and a distant dispersive electrode affixed to the thigh or back.
  • RF Radio Frequency
  • the aim of needle myolysis is to coagulate a significant volume of the tumor and thereby cause it to shrink substantially.
  • the traditional technique is to make multiple passes through different areas of the tumor using the coagulating needle to destroy many cylindrical cores of abnormal tissue.
  • Electrosurgical lesions are created when radiofrequency current flows through tissue, resistively heating it to the point of cell death. It has been demonstrated in the RF catheter ablation literature and elsewhere that maximum energy transfer occurs when the electrode tissue interface temperature remains below 100°C. Temperatures in excess of 100°C cause intracellular water to boil, desiccating tissue and reducing the electrical and thermal conductivity of the surrounding tissue. Under such conditions, the impedance seen by the ESU increases and current flow falls (since most ESUs are constant voltage sources) . Since the electrocautery electrode itself acts as a passive heat sink, the highest tissue temperature is usually found at some depth from the tissue-electrode interface. Therefore, under ideal circumstances the coagulating electrode temperature would be maintained at some level below the critical 100°C temperature (e.g., 80°C) .
  • critical 100°C temperature e.g. 80°C
  • the surgeon must set ESU power levels based upon heuristics.
  • the amount of energy required to maintain the tissue-electrode interface at the desired temperature will vary depending upon a number of factors, including the size of the coagulating needle, the blood flow in the surrounding tissue, etc. Excessive temperatures at the uterine serosa can be expected to increase the incidence of adhesion formation; this can lead to chronic pain in some patients .
  • the present invention provides electrosurgical needles, needle systems, and methods for their use which will allow the surgeon to target a tumor's blood supply.
  • the invention facilities targeting the bloodflow of the tumor by incorporating a Doppler ultrasound transducer into the needle or needle sheath.
  • the surgeon will also be able to control the temperature of the needle using an integral temperature sensor to effect maximum transfer of the electrosurgical energy into the tissue, thereby maximizing the volume of tissue destroyed.
  • the present invention will reduce damage to the serosa by monitoring the uterine surface temperature during myolysis through a temperature sensor integrated into the sheath surrounding the myolysis needle.
  • the present invention provides an electrosurgical device comprising a needle having a proximal end and a distal end, with an ultrasound transducer near the distal end.
  • a conductive surface is disposed near the distal end of the needle to induce heating of adjacent tissues when an electrical potential is applied.
  • the transducer will preferably be coupled to a Doppler ultrasound system capable of sensing bloodflow.
  • the transducer can thus be used to direct the insertion of the needle to specifically target and coagulate the bloodflow to a tumor.
  • the present invention provides an electrosurgical probe comprising a needle having a proximal end and " a distal end. The distal end is adapted for insertion into a target tissue of a patient body.
  • a conductive surface is disposed near the distal end of the needle, and is capable of heating the target tissue when the needle is inserted and an electrical potential is applied.
  • An ultrasound transducer is mounted along the needle for directing insertion of the needle toward the target tissue.
  • the conductive surface and the transducer will typically be electrically and/or thermally isolated from each other.
  • the ultrasound transducer will be affixed to the needle itself and will be inserted toward the target tissue with that structure.
  • the transducer will be mounted on a sheath surrounding the needle, ideally being distally oriented to track the path of the needle when the transducer is placed against tissue and the needle is advanced distally from the sheath.
  • the transducer will generally comprise a phased-array capable of use with a Doppler ultrasound system for sensing and color imaging of bloodflows .
  • a temperature sensor on the sheath will preferably provide feedback to the electrosurgical power source to further minimize damage to surrounding tissues.
  • the present invention provides an electrosurgical probe comprising a needle having a proximal end and a distal end, the distal end being adapted for insertion into a target tissue of a patient body.
  • the needle has a conductive surface disposed near the distal end which is capable of heating the target tissue when the needle is inserted and an electrical potential is applied.
  • a sheath is slidably disposed over the needle.
  • a temperature sensor mounted on the needle or the sheath indicates the temperature of tissues adjacent the target tissue.
  • an ultrasound transducer is mounted on the needle or the sheath.
  • the transducer is coupleable to a Doppler ultrasound system for directing insertion of the needle toward a bloodflow of the target tissue.
  • the present invention provides an electrosurgical system comprising a needle having a proximal end and a distal end, the distal end being adapted for insertion into a target tissue of a patient body.
  • the needle has a conductive surface disposed near the distal end.
  • An electrosurgical power source is coupled to the conductive surface for heating the target tissue.
  • An ultrasound transducer is mounted along the needle, and a Doppler ultrasound system is coupled to the ultrasound transducer for directing insertion of the needle toward a bloodflow of the target tissue.
  • the present invention provides a method comprising inserting a needle of a probe into tissue adjacent a tumor. A bloodflow of the tissue is sensed with an ultrasound transducer of the probe. A conducive surface on the needle is energized with electrosurgical power to coagulate the bloodflow.
  • FIG. 1 is a schematic illustration of a myolysis needle according to the principles of the present invention.
  • Fig. 2 is a schematic illustration of an alternative myolysis needle having a Doppler transducer mounted on the sheath, according to the principles of the present invention.
  • Fig. 3 schematically illustrates an electrosurgical system including the myolysis needle of Fig. 1, and also shows a method of using that system for the treatment of uterine fibroids.
  • the apparatus and methods of the present invention are particularly well suited for laparoscopically or hysteroscopically inducing shrinkage of fibroid tumors
  • the present invention will also have application in the treatment of other tumors, particularly the prostatic adenoma responsible for benign prostatic hyperplasia. Therefore, descriptions of utility in laparoscopic treatment of fibroid tumors should not be viewed as limiting the application of the technology. - For example, application of a Doppler ultrasound coagulation needle to BPH through " an operating cystoscope would also be possible.
  • a myolysis needle probe 10 generally includes a proximal end 12 and a distal end 14.
  • a needle 16 includes an ultrasound transducer 17 near its distal end.
  • the transducer has Doppler flow sensing capabilities when coupled to an appropriate ultrasound system.
  • the needle further includes an external conductive surface 18 which is coupled to an electrosurgical power unit (ESU) through proximal end 12, and is generally retractable into a sheath 20.
  • ESU electrosurgical power unit
  • Doppler ultrasound is used in medicine to detect blood flow.
  • Doppler ultrasound technology has been integrated into stethoscopes, scanning ultrasound probes, and more recently, vascular access needles.
  • An exemplary Doppler vascular access needle has been developed by Advanced Cardiovascular Systems, Inc., under the tradename SmartNeedle.
  • a Doppler ultrasound guided needle is described in U.S. Patent No. 5,259,385, the full disclosure of which is incorporated herein by reference.
  • the myolysis needle will preferably be equipped with a temperature sensor 22, such as a thermocouple or thermistor. This will enable the physician to monitor temperatures during a burn and adjust the power setting accordingly.
  • a temperature sensor 22 such as a thermocouple or thermistor.
  • Another alternative is to use the temperature sensor to close a feedback loop to the ESU, permitting continuous automatic temperature control at the ablating site.
  • the operator would set the desired needle temperature and maximum allowable ESU power.
  • the ESU would then decrease power from the setpoint as required to avoid overshooting the set-point temperature.
  • the surgeon would still see a real-time readout of the actual needle temperature.
  • An exemplary electrosurgical feedback loop is described in U.S. Patent No. 5,556,396, the full disclosure of which is incorporated by reference.
  • Needle probe 10 incorporates doppler ultrasound transducer 16 into the myolysis needle itself.
  • a sheath transducer 32 may be mounted on flow-sensing sheath 34, as shown in Fig. 2.
  • the sheath transducer permits the surgeon to target the blood supply of a fibroid, prostatic adenoma, or other tumor by placing the end of the sheath against adjacent tissues.
  • the Doppler transducer will often provide an image of bloodflow along an image plane or surface.
  • sheath transducer 32 will be distally oriented so that the Doppler image can be used to direct distal advancement of the needle, the needle ideally being adjacent an image plane.
  • Sheath transducer 32 will typically be offset to one side of the needle as shown, but may alternatively comprise an annular structure disposed coaxially about the needle, a plurality of transducers mounted about the needle, or the like.
  • the physician will locate the fibroid and extend the retractable needle to the appropriate depth and localize the blood supply with the sheath or needle mounted Doppler transducer. This information would be used to guide application of cautery with conductive surface 18. Note that if bipolar current is to be used, a pair of needles may be extended rather than a single needle. Regardless, this technique could reduce the number of passes required for definitive tumor reduction therapy, thereby reducing operating time and the risk of adhesion formation. Another benefit is that the surgeon would receive immediate feedback as to the elimination of the targeted blood flow from the Doppler ultrasound capabilities of the probe.
  • a sheath temperature sensor 36 can also be incorporated into the sheath surrounding the retractable myolysis needle.
  • This sensor provides additional feedback on the coagulation process, and is particularly beneficial for minimizing damage to tissues surrounding those targeted for electrosurgical therapy.
  • this thermal sensor can display the uterine surface temperature.
  • An alarm can sound if the surface temperature exceeds a user-selected level (e.g., 45°C) .
  • the needle myolysis device is equipped with an irrigation port 38 so that the serosa is cooled by irrigation solution during the myolysis burn, still further minimizing trauma to surrounding tissues.
  • electrosurgical needle structures and electrosurgical current pathways may be provided within the scope of the present invention.
  • current delivery may be effected via a single needle in unipolar or monopolar mode, via a pair of needles in bipolar mode, or between a single needle and a distal surface of the sheath in an alternative bipolar arrangement.
  • one or more myolysis needles could be energized by connecting electrically separated segments of each needle in parallel.
  • a proximal needle segment between the conductive surface (or surfaces) and the sheath can be left inactive, thereby sparing the uterine serosa the direct effects of resistive heating.
  • a simple device might have fixed or retractable needle(s) and an irrigation port for serosal cooling during current application.
  • the needle electrode is fixed in position, and where surface cooling is provided via irrigation, only the distal portion of the needle will be active. This structure may optionally be used by slowly withdrawing the needle while applying electrosurgical energy.
  • Other features, such as temperature sensing in the lesion, at the serosa, and Doppler assisted blood-flow localization could be added individually or together.
  • Each of these embodiments will preferably include a Doppler transducer integrated into the structure of the needle probe.
  • the most likely route of introduction of this device would be through a laparoscope, although hysteroscopic and cystoscopic use is also possible.
  • An exemplary system and method for treating uterine fibroids is schematically illustrated in Fig. 3.
  • needle probe 30 is coupled to an electrosurgical power unit 42.
  • the needle applies current in a monopolar mode, while dispersive electrode 44 will typically be affixed to the thigh or back, as described above.
  • a Doppler ultrasound image system 46 is coupled to sheath transducer 32, providing an image of bloodflow at an image plane 48.
  • the Doppler image greatly facilitates insertion of needle 16 distally from the sheath toward a bloodflow B of a tumor T.
  • electrosurgical power is applied by ESU 42 through the needle to coagulate the bloodflow.
  • the temperature of the adjacent tissue is monitored during the burn by sheath temperature sensor 36.
  • the temperature sensor is coupled to the ESU through a temperature control system 50, so as to provide the necessary coagulation with minimal trauma, such as injury to the uterine serosa, adhesion formation, and the like.
  • Cooling will typically be provided with a distal irrigation port of the sheath and irrigation fluid 52, as is generally described above.

Abstract

The present invention provides electrosurgical needles, needle systems, and methods for their use which will allow the surgeon to target a tumor's blood supply. Generally, the invention facilitates targeting the blood flow (B) of the tumor (T) by incorporating a doppler ultrasound transducer (17) into the needle (16) or needle sheath (34). Preferably, the surgeon will also be able to control the temperature of the needle (16) using an integral temperature sensor (22) to effect maximum transfer of the RF energy into the tissue (T), thereby maximizing the volume of tissue destroyed. Furthermore, when used (for example) in the treatment of uterine fibroid, the present invention will reduce damage to the serosa by monitoring the uterine surface temperature during myolysis through a temperature sensor (36) integrated into the sheath (34) holding the myolysis needle.

Description

NEEDLE MYOLYSIS SYSTEM FOR UTERINE FIBROIDS
BACKGROUND OF THE INVENTION Benign leiorayomata (uterine fibroids) are common tumors which affect more than 25% of all women at some time during the reproductive years. Many women wish to have fibroid-related symptoms such as bleeding and pain treated without resort to hysterectomy. Pharmacologic therapy alone is of limited utility due to side-effects associated with long-term use. Hysteroscopic resection using the loop or vaporizing resectoscope is appropriate for those tumors which protrude into the uterine cavity--so called submucous myomas. Surgical myomectomy (removal of the fibroid) is often used for tumors which are thought to be the cause of infertility. However, this approach usually requires a laparotomy and is often associated with adhesion formation between the uterus, bowel and other adjacent structures. These adhesions can be the cause of chronic pain in some patients.
Needle myolysis is a promising technique whereby a laparoscope is used to introduce one or more needles into a fibroid tumor under visual control. Bipolar Radio Frequency ("RF") current is then delivered between two adjacent needles, or unipolar current between a single needle and a distant dispersive electrode affixed to the thigh or back. The aim of needle myolysis is to coagulate a significant volume of the tumor and thereby cause it to shrink substantially. The traditional technique is to make multiple passes through different areas of the tumor using the coagulating needle to destroy many cylindrical cores of abnormal tissue. However, the desirability of multiple passes is mitigated by the risk of adhesion formation, which is thought to increase with increasing amounts of injured uterine serosa, and by the operative time and skill required. Recently, Goldrath and others have demonstrated that tumor shrinkage can be preferentially induced by destroying the tumor's blood supply, which is generally located on the periphery, rather than by targeting the bulk of the fibroid. Physicians acting on this observation use the needles to ring the tumor with cores of coagulation. This technique still calls for multiple tumor passes and, in the end, the operator remains uncertain as to the status of the tumor's blood supply.
Another problem with needle myolysis is the variability in generated lesion sizes created by the electrocautery generator. Electrosurgical lesions are created when radiofrequency current flows through tissue, resistively heating it to the point of cell death. It has been demonstrated in the RF catheter ablation literature and elsewhere that maximum energy transfer occurs when the electrode tissue interface temperature remains below 100°C. Temperatures in excess of 100°C cause intracellular water to boil, desiccating tissue and reducing the electrical and thermal conductivity of the surrounding tissue. Under such conditions, the impedance seen by the ESU increases and current flow falls (since most ESUs are constant voltage sources) . Since the electrocautery electrode itself acts as a passive heat sink, the highest tissue temperature is usually found at some depth from the tissue-electrode interface. Therefore, under ideal circumstances the coagulating electrode temperature would be maintained at some level below the critical 100°C temperature (e.g., 80°C) .
Today, the surgeon must set ESU power levels based upon heuristics. However, the amount of energy required to maintain the tissue-electrode interface at the desired temperature will vary depending upon a number of factors, including the size of the coagulating needle, the blood flow in the surrounding tissue, etc. Excessive temperatures at the uterine serosa can be expected to increase the incidence of adhesion formation; this can lead to chronic pain in some patients .
To overcome the above limitations, it would be desirable to provide improved needle myolysis systems and methods to facilitate the accurate, controlled targeting of a tumor's blood supply. It would further be desirable if such an apparatus could provide feedback regarding the temperature at the tissue-electrode interface, and particularly the temperature of nearby tissues.
SUMMARY OF THE INVENTION
The present invention provides electrosurgical needles, needle systems, and methods for their use which will allow the surgeon to target a tumor's blood supply.
Generally, the invention facilities targeting the bloodflow of the tumor by incorporating a Doppler ultrasound transducer into the needle or needle sheath. Preferably, the surgeon will also be able to control the temperature of the needle using an integral temperature sensor to effect maximum transfer of the electrosurgical energy into the tissue, thereby maximizing the volume of tissue destroyed. Furthermore, when used (for example) in the treatment of uterine fibroids, the present invention will reduce damage to the serosa by monitoring the uterine surface temperature during myolysis through a temperature sensor integrated into the sheath surrounding the myolysis needle.
In a first aspect, the present invention provides an electrosurgical device comprising a needle having a proximal end and a distal end, with an ultrasound transducer near the distal end. A conductive surface is disposed near the distal end of the needle to induce heating of adjacent tissues when an electrical potential is applied. The transducer will preferably be coupled to a Doppler ultrasound system capable of sensing bloodflow. Advantageously, the transducer can thus be used to direct the insertion of the needle to specifically target and coagulate the bloodflow to a tumor. In another aspect, the present invention provides an electrosurgical probe comprising a needle having a proximal end and"a distal end. The distal end is adapted for insertion into a target tissue of a patient body. A conductive surface is disposed near the distal end of the needle, and is capable of heating the target tissue when the needle is inserted and an electrical potential is applied. An ultrasound transducer is mounted along the needle for directing insertion of the needle toward the target tissue. The conductive surface and the transducer will typically be electrically and/or thermally isolated from each other. In some embodiments, the ultrasound transducer will be affixed to the needle itself and will be inserted toward the target tissue with that structure. In alternative embodiments, the transducer will be mounted on a sheath surrounding the needle, ideally being distally oriented to track the path of the needle when the transducer is placed against tissue and the needle is advanced distally from the sheath. Regardless, the transducer will generally comprise a phased-array capable of use with a Doppler ultrasound system for sensing and color imaging of bloodflows . A temperature sensor on the sheath will preferably provide feedback to the electrosurgical power source to further minimize damage to surrounding tissues. In another aspect, the present invention provides an electrosurgical probe comprising a needle having a proximal end and a distal end, the distal end being adapted for insertion into a target tissue of a patient body. The needle has a conductive surface disposed near the distal end which is capable of heating the target tissue when the needle is inserted and an electrical potential is applied. A sheath is slidably disposed over the needle. A temperature sensor mounted on the needle or the sheath indicates the temperature of tissues adjacent the target tissue. Preferably, an ultrasound transducer is mounted on the needle or the sheath.
The transducer is coupleable to a Doppler ultrasound system for directing insertion of the needle toward a bloodflow of the target tissue. In another aspect, the present invention provides an electrosurgical system comprising a needle having a proximal end and a distal end, the distal end being adapted for insertion into a target tissue of a patient body. The needle has a conductive surface disposed near the distal end. An electrosurgical power source is coupled to the conductive surface for heating the target tissue. An ultrasound transducer is mounted along the needle, and a Doppler ultrasound system is coupled to the ultrasound transducer for directing insertion of the needle toward a bloodflow of the target tissue.
In another aspect, the present invention provides a method comprising inserting a needle of a probe into tissue adjacent a tumor. A bloodflow of the tissue is sensed with an ultrasound transducer of the probe. A conducive surface on the needle is energized with electrosurgical power to coagulate the bloodflow.
BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a schematic illustration of a myolysis needle according to the principles of the present invention.
Fig. 2 is a schematic illustration of an alternative myolysis needle having a Doppler transducer mounted on the sheath, according to the principles of the present invention. Fig. 3 schematically illustrates an electrosurgical system including the myolysis needle of Fig. 1, and also shows a method of using that system for the treatment of uterine fibroids.
DETAILED DESCRIPTION OF THE SPECIFIC EMBODIMENTS
It should be noted that while the apparatus and methods of the present invention are particularly well suited for laparoscopically or hysteroscopically inducing shrinkage of fibroid tumors, the present invention will also have application in the treatment of other tumors, particularly the prostatic adenoma responsible for benign prostatic hyperplasia. Therefore, descriptions of utility in laparoscopic treatment of fibroid tumors should not be viewed as limiting the application of the technology. - For example, application of a Doppler ultrasound coagulation needle to BPH through"an operating cystoscope would also be possible.
Referring now to Fig. 1, a myolysis needle probe 10 generally includes a proximal end 12 and a distal end 14. A needle 16 includes an ultrasound transducer 17 near its distal end. The transducer has Doppler flow sensing capabilities when coupled to an appropriate ultrasound system. The needle further includes an external conductive surface 18 which is coupled to an electrosurgical power unit (ESU) through proximal end 12, and is generally retractable into a sheath 20. Hence, in this embodiment, the transducer will be inserted toward the target tissues with the needle.
Doppler ultrasound is used in medicine to detect blood flow. Doppler ultrasound technology has been integrated into stethoscopes, scanning ultrasound probes, and more recently, vascular access needles. An exemplary Doppler vascular access needle has been developed by Advanced Cardiovascular Systems, Inc., under the tradename SmartNeedle. A Doppler ultrasound guided needle is described in U.S. Patent No. 5,259,385, the full disclosure of which is incorporated herein by reference.
The myolysis needle will preferably be equipped with a temperature sensor 22, such as a thermocouple or thermistor. This will enable the physician to monitor temperatures during a burn and adjust the power setting accordingly. Another alternative is to use the temperature sensor to close a feedback loop to the ESU, permitting continuous automatic temperature control at the ablating site. In this embodiment, the operator would set the desired needle temperature and maximum allowable ESU power. The ESU would then decrease power from the setpoint as required to avoid overshooting the set-point temperature. In this example, the surgeon would still see a real-time readout of the actual needle temperature. An exemplary electrosurgical feedback loop is described in U.S. Patent No. 5,556,396, the full disclosure of which is incorporated by reference. Needle probe 10 incorporates doppler ultrasound transducer 16 into the myolysis needle itself. In an alternative needle probe 30, a sheath transducer 32 may be mounted on flow-sensing sheath 34, as shown in Fig. 2. The sheath transducer permits the surgeon to target the blood supply of a fibroid, prostatic adenoma, or other tumor by placing the end of the sheath against adjacent tissues. As is known in the art, the Doppler transducer will often provide an image of bloodflow along an image plane or surface. Preferably, sheath transducer 32 will be distally oriented so that the Doppler image can be used to direct distal advancement of the needle, the needle ideally being adjacent an image plane. Sheath transducer 32 will typically be offset to one side of the needle as shown, but may alternatively comprise an annular structure disposed coaxially about the needle, a plurality of transducers mounted about the needle, or the like.
In the preferred embodiment of the method of the present invention, the physician will locate the fibroid and extend the retractable needle to the appropriate depth and localize the blood supply with the sheath or needle mounted Doppler transducer. This information would be used to guide application of cautery with conductive surface 18. Note that if bipolar current is to be used, a pair of needles may be extended rather than a single needle. Regardless, this technique could reduce the number of passes required for definitive tumor reduction therapy, thereby reducing operating time and the risk of adhesion formation. Another benefit is that the surgeon would receive immediate feedback as to the elimination of the targeted blood flow from the Doppler ultrasound capabilities of the probe.
Referring still to Fig. 2, a sheath temperature sensor 36, typically a thermocouple or thermistor, can also be incorporated into the sheath surrounding the retractable myolysis needle. This sensor provides additional feedback on the coagulation process, and is particularly beneficial for minimizing damage to tissues surrounding those targeted for electrosurgical therapy. When pressed against the serosal surface of the uterus, for example, this thermal sensor can display the uterine surface temperature. An alarm can sound if the surface temperature exceeds a user-selected level (e.g., 45°C) . In the exemplary embodiment, the needle myolysis device is equipped with an irrigation port 38 so that the serosa is cooled by irrigation solution during the myolysis burn, still further minimizing trauma to surrounding tissues.
A wide variety of alternative electrosurgical needle structures and electrosurgical current pathways may be provided within the scope of the present invention. Generally, current delivery may be effected via a single needle in unipolar or monopolar mode, via a pair of needles in bipolar mode, or between a single needle and a distal surface of the sheath in an alternative bipolar arrangement.
Alternatively, one or more myolysis needles could be energized by connecting electrically separated segments of each needle in parallel. In some embodiments, depending upon the amount of needle exposed from the sheath, a proximal needle segment between the conductive surface (or surfaces) and the sheath can be left inactive, thereby sparing the uterine serosa the direct effects of resistive heating. A simple device might have fixed or retractable needle(s) and an irrigation port for serosal cooling during current application. Optionally, where the needle electrode is fixed in position, and where surface cooling is provided via irrigation, only the distal portion of the needle will be active. This structure may optionally be used by slowly withdrawing the needle while applying electrosurgical energy. Other features, such as temperature sensing in the lesion, at the serosa, and Doppler assisted blood-flow localization could be added individually or together.
Each of these embodiments will preferably include a Doppler transducer integrated into the structure of the needle probe. The most likely route of introduction of this device would be through a laparoscope, although hysteroscopic and cystoscopic use is also possible. An exemplary system and method for treating uterine fibroids is schematically illustrated in Fig. 3. In a needle system 40, needle probe 30 is coupled to an electrosurgical power unit 42. Here, the needle applies current in a monopolar mode, while dispersive electrode 44 will typically be affixed to the thigh or back, as described above. A Doppler ultrasound image system 46 is coupled to sheath transducer 32, providing an image of bloodflow at an image plane 48. As the needle and transducer are integrated into a single probe structure, and as needle 16 extends along image plane 48, the Doppler image greatly facilitates insertion of needle 16 distally from the sheath toward a bloodflow B of a tumor T. Once the Doppler image system indicates that the needle is adjacent the vessel which is supplying blood to the tumor, electrosurgical power is applied by ESU 42 through the needle to coagulate the bloodflow. Optionally, the temperature of the adjacent tissue is monitored during the burn by sheath temperature sensor 36. Ideally, the temperature sensor is coupled to the ESU through a temperature control system 50, so as to provide the necessary coagulation with minimal trauma, such as injury to the uterine serosa, adhesion formation, and the like. Cooling will typically be provided with a distal irrigation port of the sheath and irrigation fluid 52, as is generally described above Although the specific embodiments have been described in some detail, by way of illustration and for clarity of understanding, a variety of modifications, adaptations and alternatives will be obvious to those of skill in the art. Therefore, the scope of the present invention is limited solely by the appended claims.

Claims

WHAT IS CLAIMED IS:
I. A device comprising: an electrosurgical needle having a proximal end and a distal end; an ultrasound transducer near the distal end; and a conductive surface disposed near the distal end of the needle to induce heating of adjacent tissues when an electrical potential is applied.
2. An electrosurgical probe comprising: a needle having a proximal end and a distal end, the distal end being adapted for insertion into a target tissue of a patient body; a conductive surface disposed near the distal end of the needle, the conductive surface capable of heating the target tissue when the needle is inserted and an electrical potential is applied; and an ultrasound transducer mounted along the needle for directing insertion of the needle toward the target tissue.
3. An electrosurgical probe as claimed in claim 2, wherein the ultrasound transducer is adapted for use with a Doppler ultrasound system to sense bloodflow through the target tissue.
4. An electrosurgical probe as claimed in claim 3, wherein the ultrasound transducer is insertable with the needle.
5. An electrosurgical probe as claimed in claim 3, further comprising a temperature sensor disposable near the distal end of the needle for monitoring a temperature of the target tissue.
6. An electrosurgical probe as claimed in claim 3, further comprising a sheath slidably disposed over the needle.
7. An electrosurgical probe as claimed in claim 6, wherein the ultrasound transducer is mounted near a distal end of the sheath.
8. An electrosurgical probe as claimed in claim 7, wherein the ultrasound transducer is distally oriented to direct distal insertion of the needle toward the bloodflow.
9. An electrosurgical probe as claimed in claim 8, further comprising a flow path for a solution which cools tissues adjacent the probe, the cooling flow path being disposed within the sheath.
10. An electrosurgical probe comprising: a needle having a proximal end and a distal end, the distal end being adapted for insertion into a target tissue of a patient body, the needle having a conductive surface disposed near the distal end, the conductive surface capable of heating the target tissue when the needle is inserted and an electrical potential is applied thereto; a sheath slidably disposed over the needle; and a temperature sensor mounted on the needle or the sheath, the temperature sensor capable of indicating the temperature of tissues adjacent the target tissue.
11. An electrosurgical probe as claimed in claim 10, further comprising an ultrasound transducer mounted on the needle or the sheath, the transducer coupleable to a Doppler ultrasound system for directing insertion of the needle toward a bloodflow of the target tissue.
12. An electrosurgical system comprising: a needle having a proximal end and a distal end, the distal end being adapted for insertion into a target tissue of a patient body, the needle having a conductive -surface disposed near the distal end; an electrosurgical power source coupled to the conductive surface for heating the target tissue; an ultrasound transducer mounted along the needle; and a Doppler ultrasound system coupled to the ultrasound transducer for directing insertion of the needle toward a bloodflow of the target tissue.
12. An electrosurgical system as claimed in claim ll, further comprising a temperature sensor mounted on at least one of the needle and the sheath, wherein the temperature sensor is coupled to the electrosurgical power source so as to control heating of the tissue based on the target tissue temperature.
13. A method for treating tumorous tissue, the method comprising: inserting a needle of a probe into tissue adjacent a tumor; sensing a bloodflow of the tissue with an ultrasound transducer of the probe; and energizing a conductive surface on the needle with electrosurgical power to coagulate the bloodflow.
14. A method as claimed in claim 13, wherein the inserting step is directed toward the bloodflow with a Doppler ultrasound image provided from the sensing step.
15. A method as claimed in claim 13, further comprising sensing a temperature of the tissue with a sensor of the probe.
16. A method as claimed in claim 13, wherein the inserting step comprises extending the needle from a sheath of the probe, and wherein the ultrasound transducer is mounted on the sheath.
PCT/US1996/017923 1995-11-09 1996-11-07 Needle myolysis system for uterine fibroids WO1997017105A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US639695P 1995-11-09 1995-11-09
US60/006,396 1995-11-09
USNOTFURNISHED 1998-03-11

Publications (1)

Publication Number Publication Date
WO1997017105A1 true WO1997017105A1 (en) 1997-05-15

Family

ID=21720661

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/017923 WO1997017105A1 (en) 1995-11-09 1996-11-07 Needle myolysis system for uterine fibroids

Country Status (2)

Country Link
US (1) US5979453A (en)
WO (1) WO1997017105A1 (en)

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1066067A1 (en) * 1998-02-27 2001-01-10 Micro Therapeutics, Inc. Gynecologic embolotherapy methods
US6425854B1 (en) 2000-10-02 2002-07-30 Genyx Medical, Inc. Method for delivering non-biodegradable bulking composition to a urological site
US6478775B1 (en) 2000-10-02 2002-11-12 Genyx Medical Inc. Device for delivering non-biodegradable bulking composition to a urological site
EP1143864B1 (en) * 1999-08-05 2004-02-04 Broncus Technologies, Inc. Methods and devices for creating collateral channels in the lungs
WO2004064658A1 (en) * 2003-01-16 2004-08-05 Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Medical Center Echogenic needle for transvaginal ultrasound directed reduction of uterine fibroids and an associated method
WO2006024161A1 (en) * 2004-09-03 2006-03-09 Diros Technology Inc. Method and apparatus for delivering energy via a hybrid cannula/electrode medical device
WO2006095171A1 (en) * 2005-03-10 2006-09-14 Emcision Limited Device and method for the treatment of diseased tissue such as tumours
US8357176B2 (en) 2006-07-24 2013-01-22 Fibro Control, Inc. Fibroid treatment apparatus and method
US20130046230A1 (en) * 2010-03-05 2013-02-21 Cornell University Ultrasound-assisted convection enhanced delivery of compounds in vivo with a transducer cannula assembly
US8403953B2 (en) 2009-07-27 2013-03-26 Fibro Control, Inc. Balloon with rigid tube for occluding the uterine artery
US8932316B2 (en) 2011-05-13 2015-01-13 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US9345532B2 (en) 2011-05-13 2016-05-24 Broncus Medical Inc. Methods and devices for ablation of tissue
US9357977B2 (en) 2006-01-12 2016-06-07 Gynesonics, Inc. Interventional deployment and imaging system
US9533128B2 (en) 2003-07-18 2017-01-03 Broncus Medical Inc. Devices for maintaining patency of surgically created channels in tissue
US9808310B2 (en) 2005-02-02 2017-11-07 Gynesonics, Inc. Method and device for uterine fibroid treatment
US9913969B2 (en) 2006-10-05 2018-03-13 Broncus Medical Inc. Devices for delivering substances through an extra-anatomic opening created in an airway
US9919129B2 (en) 2012-12-18 2018-03-20 Alcyone Lifesciences, Inc. Systems and methods for reducing or preventing backflow in a delivery system
US10058342B2 (en) 2006-01-12 2018-08-28 Gynesonics, Inc. Devices and methods for treatment of tissue
US10137244B2 (en) 2011-08-01 2018-11-27 Alcyone Lifesciences, Inc. Microfluidic drug delivery devices with venturi effect
US10272260B2 (en) 2011-11-23 2019-04-30 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US10321951B2 (en) 2009-02-27 2019-06-18 Gynesonics, Inc. Needle and tine deployment mechanism
US10441770B2 (en) 2013-07-31 2019-10-15 Alcyone Lifesciences, Inc. Systems and methods for drug delivery, treatment, and monitoring
US10456533B2 (en) 2013-06-17 2019-10-29 Alcyone Lifesciences, Inc. Methods and devices for protecting catheter tips and stereotactic fixtures for microcatheters
US10531882B2 (en) 2016-01-04 2020-01-14 Alcyone Lifesciences, Inc. Methods and devices for treating stroke
US10595819B2 (en) 2006-04-20 2020-03-24 Gynesonics, Inc. Ablation device with articulated imaging transducer
US10806396B2 (en) 2015-01-26 2020-10-20 Alcyone Lifesciences, Inc. Drug delivery methods with tracer
US10993770B2 (en) 2016-11-11 2021-05-04 Gynesonics, Inc. Controlled treatment of tissue and dynamic interaction with, and comparison of, tissue and/or treatment data
US11259825B2 (en) 2006-01-12 2022-03-01 Gynesonics, Inc. Devices and methods for treatment of tissue
US11832877B2 (en) 2017-04-03 2023-12-05 Broncus Medical Inc. Electrosurgical access sheath

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254601B1 (en) * 1998-12-08 2001-07-03 Hysterx, Inc. Methods for occlusion of the uterine arteries
CA2387127A1 (en) 1999-10-25 2001-05-17 Therus Corporation Use of focused ultrasound for vascular sealing
US6626855B1 (en) * 1999-11-26 2003-09-30 Therus Corpoation Controlled high efficiency lesion formation using high intensity ultrasound
US7223279B2 (en) 2000-04-21 2007-05-29 Vascular Control Systems, Inc. Methods for minimally-invasive, non-permanent occlusion of a uterine artery
US6550482B1 (en) 2000-04-21 2003-04-22 Vascular Control Systems, Inc. Methods for non-permanent occlusion of a uterine artery
US6840935B2 (en) * 2000-08-09 2005-01-11 Bekl Corporation Gynecological ablation procedure and system using an ablation needle
US7678106B2 (en) * 2000-08-09 2010-03-16 Halt Medical, Inc. Gynecological ablation procedure and system
US6635065B2 (en) * 2000-11-16 2003-10-21 Vascular Control Systems, Inc. Doppler directed suture ligation device and method
US6638286B1 (en) 2000-11-16 2003-10-28 Vascular Control Systems, Inc. Doppler directed suture ligation device and method
CA2442362C (en) * 2001-03-28 2009-08-11 Vascular Control Systems, Inc. Method and apparatus for the detection and ligation of uterine arteries
US7354444B2 (en) 2001-03-28 2008-04-08 Vascular Control Systems, Inc. Occlusion device with deployable paddles for detection and occlusion of blood vessels
US7846096B2 (en) 2001-05-29 2010-12-07 Ethicon Endo-Surgery, Inc. Method for monitoring of medical treatment using pulse-echo ultrasound
US20030032898A1 (en) 2001-05-29 2003-02-13 Inder Raj. S. Makin Method for aiming ultrasound for medical treatment
US7207996B2 (en) * 2002-04-04 2007-04-24 Vascular Control Systems, Inc. Doppler directed suturing and compression device and method
US6892090B2 (en) * 2002-08-19 2005-05-10 Surgical Navigation Technologies, Inc. Method and apparatus for virtual endoscopy
US20040097961A1 (en) * 2002-11-19 2004-05-20 Vascular Control System Tenaculum for use with occlusion devices
US7172603B2 (en) * 2002-11-19 2007-02-06 Vascular Control Systems, Inc. Deployable constrictor for uterine artery occlusion
US7404821B2 (en) 2003-01-30 2008-07-29 Vascular Control Systems, Inc. Treatment for post partum hemorrhage
US7651511B2 (en) 2003-02-05 2010-01-26 Vascular Control Systems, Inc. Vascular clamp for caesarian section
US7333844B2 (en) 2003-03-28 2008-02-19 Vascular Control Systems, Inc. Uterine tissue monitoring device and method
US7325546B2 (en) * 2003-11-20 2008-02-05 Vascular Control Systems, Inc. Uterine artery occlusion device with cervical receptacle
US7686817B2 (en) 2003-11-25 2010-03-30 Vascular Control Systems, Inc. Occlusion device for asymmetrical uterine artery anatomy
US7883468B2 (en) 2004-05-18 2011-02-08 Ethicon Endo-Surgery, Inc. Medical system having an ultrasound source and an acoustic coupling medium
US7951095B2 (en) 2004-05-20 2011-05-31 Ethicon Endo-Surgery, Inc. Ultrasound medical system
US7695436B2 (en) 2004-05-21 2010-04-13 Ethicon Endo-Surgery, Inc. Transmit apodization of an ultrasound transducer array
US7806839B2 (en) 2004-06-14 2010-10-05 Ethicon Endo-Surgery, Inc. System and method for ultrasound therapy using grating lobes
US20060015144A1 (en) * 2004-07-19 2006-01-19 Vascular Control Systems, Inc. Uterine artery occlusion staple
US7875036B2 (en) 2004-10-27 2011-01-25 Vascular Control Systems, Inc. Short term treatment for uterine disorder
US20060106315A1 (en) * 2004-11-17 2006-05-18 Roger Edens Guided hypodermic cannula
US9339323B2 (en) 2005-05-12 2016-05-17 Aesculap Ag Electrocautery method and apparatus
US8696662B2 (en) 2005-05-12 2014-04-15 Aesculap Ag Electrocautery method and apparatus
US7942874B2 (en) 2005-05-12 2011-05-17 Aragon Surgical, Inc. Apparatus for tissue cauterization
US8728072B2 (en) 2005-05-12 2014-05-20 Aesculap Ag Electrocautery method and apparatus
US20070005061A1 (en) * 2005-06-30 2007-01-04 Forcept, Inc. Transvaginal uterine artery occlusion
US8512333B2 (en) 2005-07-01 2013-08-20 Halt Medical Inc. Anchored RF ablation device for the destruction of tissue masses
US8080009B2 (en) 2005-07-01 2011-12-20 Halt Medical Inc. Radio frequency ablation device for the destruction of tissue masses
US7641651B2 (en) 2005-07-28 2010-01-05 Aragon Surgical, Inc. Devices and methods for mobilization of the uterus
US20070233185A1 (en) 2005-10-20 2007-10-04 Thomas Anderson Systems and methods for sealing a vascular opening
US9179897B2 (en) * 2005-12-13 2015-11-10 Cardiva Medical, Inc. Vascular closure devices and methods providing hemostatic enhancement
US7691127B2 (en) * 2005-12-13 2010-04-06 Cardiva Medical, Inc. Drug eluting vascular closure devices and methods
US7815571B2 (en) 2006-04-20 2010-10-19 Gynesonics, Inc. Rigid delivery systems having inclined ultrasound and needle
US7874986B2 (en) 2006-04-20 2011-01-25 Gynesonics, Inc. Methods and devices for visualization and ablation of tissue
US20220175405A1 (en) * 2006-01-12 2022-06-09 Gynesonics, Inc. Devices and methods for treatment of tissue
US20070244529A1 (en) * 2006-04-18 2007-10-18 Zoom Therapeutics, Inc. Apparatus and methods for treatment of nasal tissue
US8206300B2 (en) 2008-08-26 2012-06-26 Gynesonics, Inc. Ablation device with articulated imaging transducer
US8574229B2 (en) 2006-05-02 2013-11-05 Aesculap Ag Surgical tool
US20080027520A1 (en) * 2006-07-25 2008-01-31 Zoom Therapeutics, Inc. Laser treatment of tissue
US20080027423A1 (en) * 2006-07-25 2008-01-31 Zoom Therapeutics, Inc. Systems for treatment of nasal tissue
US8298145B2 (en) * 2006-08-01 2012-10-30 Gynesonics, Inc. Peri-capsular fibroid treatment
US8684935B2 (en) * 2007-04-12 2014-04-01 Doheny Eye Institute Intraocular ultrasound doppler techniques
WO2009042268A1 (en) * 2007-09-28 2009-04-02 Choi George Y Device and methods for treatment of tissue
US8088072B2 (en) 2007-10-12 2012-01-03 Gynesonics, Inc. Methods and systems for controlled deployment of needles in tissue
US8241276B2 (en) 2007-11-14 2012-08-14 Halt Medical Inc. RF ablation device with jam-preventing electrical coupling member
US8251991B2 (en) 2007-11-14 2012-08-28 Halt Medical Inc. Anchored RF ablation device for the destruction of tissue masses
US8870867B2 (en) 2008-02-06 2014-10-28 Aesculap Ag Articulable electrosurgical instrument with a stabilizable articulation actuator
WO2011006067A1 (en) 2009-07-09 2011-01-13 Ams Research Corporation Apparatus and methods of treatment of pathologic proliferative conditions uterine tissue
US20110118600A1 (en) 2009-11-16 2011-05-19 Michael Gertner External Autonomic Modulation
US8469904B2 (en) 2009-10-12 2013-06-25 Kona Medical, Inc. Energetic modulation of nerves
US9119951B2 (en) 2009-10-12 2015-09-01 Kona Medical, Inc. Energetic modulation of nerves
US8986211B2 (en) 2009-10-12 2015-03-24 Kona Medical, Inc. Energetic modulation of nerves
US8517962B2 (en) 2009-10-12 2013-08-27 Kona Medical, Inc. Energetic modulation of nerves
US8295912B2 (en) 2009-10-12 2012-10-23 Kona Medical, Inc. Method and system to inhibit a function of a nerve traveling with an artery
US20160059044A1 (en) 2009-10-12 2016-03-03 Kona Medical, Inc. Energy delivery to intraparenchymal regions of the kidney to treat hypertension
US8986231B2 (en) 2009-10-12 2015-03-24 Kona Medical, Inc. Energetic modulation of nerves
US20110092880A1 (en) 2009-10-12 2011-04-21 Michael Gertner Energetic modulation of nerves
US9174065B2 (en) 2009-10-12 2015-11-03 Kona Medical, Inc. Energetic modulation of nerves
CN102596080B (en) 2010-02-04 2016-04-20 蛇牌股份公司 Laparoscopic radiofrequency surgical device
US8419727B2 (en) 2010-03-26 2013-04-16 Aesculap Ag Impedance mediated power delivery for electrosurgery
US8827992B2 (en) 2010-03-26 2014-09-09 Aesculap Ag Impedance mediated control of power delivery for electrosurgery
US9173698B2 (en) 2010-09-17 2015-11-03 Aesculap Ag Electrosurgical tissue sealing augmented with a seal-enhancing composition
US9339327B2 (en) 2011-06-28 2016-05-17 Aesculap Ag Electrosurgical tissue dissecting device
KR102210195B1 (en) 2012-09-26 2021-01-29 아에스쿨랍 아게 Apparatus for tissue cutting and sealing
US20140378963A1 (en) * 2013-06-20 2014-12-25 Gyrus Acmi, Inc., D.B.A. Olympus Surgical Technologies America Treatment of uterine fibroids by arterial ablation
WO2015058096A1 (en) 2013-10-18 2015-04-23 Ziva Medical, Inc. Methods and systems for the treatment of polycystic ovary syndrome
US10925579B2 (en) 2014-11-05 2021-02-23 Otsuka Medical Devices Co., Ltd. Systems and methods for real-time tracking of a target tissue using imaging before and during therapy delivery
CN107635474B (en) 2015-03-31 2022-01-07 阿布拉护理公司 Methods and systems for manipulating ovarian tissue
US11723718B2 (en) * 2015-06-02 2023-08-15 Heartlander Surgical, Inc. Therapy delivery system that operates on the surface of an anatomical entity
EP3638126A4 (en) 2017-05-04 2021-03-10 Gynesonics, Inc. Methods for monitoring ablation progress with doppler ultrasound
CA3127560A1 (en) 2019-01-25 2020-07-30 AblaCare SAS Systems and methods for applying energy to ovarian tissue
CN109674530A (en) * 2019-03-02 2019-04-26 合肥赫博医疗器械有限责任公司 The solidifying myomata of cutting of electric heating for preventing tumour spread transfer bores crow bar
CA3124911A1 (en) * 2020-07-15 2022-01-15 Orthosoft Ulc Integrated robotic surgery system with tourniquet system

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5209721A (en) * 1992-01-31 1993-05-11 Wilk Peter J Laparoscopic surgical device and related method
US5259385A (en) * 1991-12-23 1993-11-09 Advanced Cardiovascular Systems, Inc. Apparatus for the cannulation of blood vessels
US5335663A (en) * 1992-12-11 1994-08-09 Tetrad Corporation Laparoscopic probes and probe sheaths useful in ultrasonic imaging applications
US5385544A (en) * 1992-08-12 1995-01-31 Vidamed, Inc. BPH ablation method and apparatus

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3556079A (en) * 1967-05-16 1971-01-19 Haruo Omizo Method of puncturing a medical instrument under guidance of ultrasound
US3698394A (en) * 1971-06-14 1972-10-17 William S Piper Electrically heated hypodermic needle
US5370675A (en) * 1992-08-12 1994-12-06 Vidamed, Inc. Medical probe device and method
US4887606A (en) * 1986-09-18 1989-12-19 Yock Paul G Apparatus for use in cannulation of blood vessels
US5588432A (en) * 1988-03-21 1996-12-31 Boston Scientific Corporation Catheters for imaging, sensing electrical potentials, and ablating tissue
US4960109A (en) * 1988-06-21 1990-10-02 Massachusetts Institute Of Technology Multi-purpose temperature sensing probe for hyperthermia therapy
US5192267A (en) * 1989-01-23 1993-03-09 Nadiv Shapira Vortex smoke remover for electrosurgical devices
US5391144A (en) * 1990-02-02 1995-02-21 Olympus Optical Co., Ltd. Ultrasonic treatment apparatus
US5323778A (en) * 1991-11-05 1994-06-28 Brigham & Women's Hospital Method and apparatus for magnetic resonance imaging and heating tissues
DK171113B1 (en) * 1992-01-21 1996-06-17 Baltic Technology Aps Apparatus for removing biological tissue and with an ultrasonic vibrating probe, and method for making the apparatus
US5259386A (en) * 1992-06-19 1993-11-09 Advanced Cardiovascular Systems, Inc. Flow monitor and vascular access system with continuously variable frequency control
US5342298A (en) * 1992-07-31 1994-08-30 Advanced Cardiovascular Systems, Inc. Automated fluid pressure control system
WO1994010924A1 (en) * 1992-11-13 1994-05-26 American Cardiac Ablation Co., Inc. Fluid cooled electrosurgical probe
US5403311A (en) * 1993-03-29 1995-04-04 Boston Scientific Corporation Electro-coagulation and ablation and other electrotherapeutic treatments of body tissue
US5336111A (en) * 1993-09-28 1994-08-09 The Whitaker Corporation Boardlock for an electrical connector
US5456689A (en) * 1993-10-13 1995-10-10 Arnold J. Kresch Method and device for tissue resection
US5472441A (en) * 1993-11-08 1995-12-05 Zomed International Device for treating cancer and non-malignant tumors and methods
US5599345A (en) * 1993-11-08 1997-02-04 Zomed International, Inc. RF treatment apparatus
US5536267A (en) * 1993-11-08 1996-07-16 Zomed International Multiple electrode ablation apparatus
US5368032A (en) * 1993-11-09 1994-11-29 General Electric Company Manually positioned focussed energy system guided by medical imaging
WO1995019148A1 (en) * 1994-01-18 1995-07-20 Endovascular, Inc. Apparatus and method for venous ligation
US5462545A (en) * 1994-01-31 1995-10-31 New England Medical Center Hospitals, Inc. Catheter electrodes
US5814043A (en) * 1996-09-06 1998-09-29 Mentor Ophthalmics, Inc. Bipolar electrosurgical device

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5259385A (en) * 1991-12-23 1993-11-09 Advanced Cardiovascular Systems, Inc. Apparatus for the cannulation of blood vessels
US5209721A (en) * 1992-01-31 1993-05-11 Wilk Peter J Laparoscopic surgical device and related method
US5385544A (en) * 1992-08-12 1995-01-31 Vidamed, Inc. BPH ablation method and apparatus
US5335663A (en) * 1992-12-11 1994-08-09 Tetrad Corporation Laparoscopic probes and probe sheaths useful in ultrasonic imaging applications

Cited By (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1066067A4 (en) * 1998-02-27 2001-03-14 Micro Therapeutics Inc Gynecologic embolotherapy methods
EP1066067A1 (en) * 1998-02-27 2001-01-10 Micro Therapeutics, Inc. Gynecologic embolotherapy methods
EP1625871A1 (en) * 1998-02-27 2006-02-15 Micro Therapeutics, Inc. Gynecological embolization
EP1143864B1 (en) * 1999-08-05 2004-02-04 Broncus Technologies, Inc. Methods and devices for creating collateral channels in the lungs
US6979317B2 (en) 2000-10-02 2005-12-27 Genyx Medical, Inc. Device for delivering non-biodegradable bulking composition to a urological site
US6425854B1 (en) 2000-10-02 2002-07-30 Genyx Medical, Inc. Method for delivering non-biodegradable bulking composition to a urological site
US6478775B1 (en) 2000-10-02 2002-11-12 Genyx Medical Inc. Device for delivering non-biodegradable bulking composition to a urological site
US6936048B2 (en) 2003-01-16 2005-08-30 Charlotte-Mecklenburg Hospital Authority Echogenic needle for transvaginal ultrasound directed reduction of uterine fibroids and an associated method
WO2004064658A1 (en) * 2003-01-16 2004-08-05 Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Medical Center Echogenic needle for transvaginal ultrasound directed reduction of uterine fibroids and an associated method
US9533128B2 (en) 2003-07-18 2017-01-03 Broncus Medical Inc. Devices for maintaining patency of surgically created channels in tissue
US11357960B2 (en) 2004-07-19 2022-06-14 Broncus Medical Inc. Devices for delivering substances through an extra-anatomic opening created in an airway
US10369339B2 (en) 2004-07-19 2019-08-06 Broncus Medical Inc. Devices for delivering substances through an extra-anatomic opening created in an airway
WO2006024161A1 (en) * 2004-09-03 2006-03-09 Diros Technology Inc. Method and apparatus for delivering energy via a hybrid cannula/electrode medical device
US7318822B2 (en) 2004-09-03 2008-01-15 Diros Technology Inc. Hybrid cannula/electrode medical device and method
US11950837B2 (en) 2005-02-02 2024-04-09 Gynesonics, Inc. Method and device for uterine fibroid treatment
US9987080B2 (en) 2005-02-02 2018-06-05 Gynesonics, Inc. Method and device for uterine fibroid treatment
US10182862B2 (en) 2005-02-02 2019-01-22 Gynesonics, Inc. Method and device for uterine fibroid treatment
US9808310B2 (en) 2005-02-02 2017-11-07 Gynesonics, Inc. Method and device for uterine fibroid treatment
US11419668B2 (en) 2005-02-02 2022-08-23 Gynesonics, Inc. Method and device for uterine fibroid treatment
WO2006095171A1 (en) * 2005-03-10 2006-09-14 Emcision Limited Device and method for the treatment of diseased tissue such as tumours
US11259825B2 (en) 2006-01-12 2022-03-01 Gynesonics, Inc. Devices and methods for treatment of tissue
US9517047B2 (en) 2006-01-12 2016-12-13 Gynesonics, Inc. Interventional deployment and imaging system
US9357977B2 (en) 2006-01-12 2016-06-07 Gynesonics, Inc. Interventional deployment and imaging system
US10058342B2 (en) 2006-01-12 2018-08-28 Gynesonics, Inc. Devices and methods for treatment of tissue
US10610197B2 (en) 2006-04-20 2020-04-07 Gynesonics, Inc. Ablation device with articulated imaging transducer
US10595819B2 (en) 2006-04-20 2020-03-24 Gynesonics, Inc. Ablation device with articulated imaging transducer
US8357176B2 (en) 2006-07-24 2013-01-22 Fibro Control, Inc. Fibroid treatment apparatus and method
US9913969B2 (en) 2006-10-05 2018-03-13 Broncus Medical Inc. Devices for delivering substances through an extra-anatomic opening created in an airway
US11564735B2 (en) 2009-02-27 2023-01-31 Gynesonics, Inc. Needle and fine deployment mechanism
US10321951B2 (en) 2009-02-27 2019-06-18 Gynesonics, Inc. Needle and tine deployment mechanism
US8403953B2 (en) 2009-07-27 2013-03-26 Fibro Control, Inc. Balloon with rigid tube for occluding the uterine artery
US20130046230A1 (en) * 2010-03-05 2013-02-21 Cornell University Ultrasound-assisted convection enhanced delivery of compounds in vivo with a transducer cannula assembly
US10537725B2 (en) * 2010-03-05 2020-01-21 Cornell University Ultrasound-assisted convection enhanced delivery of compounds in vivo with a transducer cannula assembly
US10631938B2 (en) 2011-05-13 2020-04-28 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US9993306B2 (en) 2011-05-13 2018-06-12 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US9345532B2 (en) 2011-05-13 2016-05-24 Broncus Medical Inc. Methods and devices for ablation of tissue
US9421070B2 (en) 2011-05-13 2016-08-23 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US8932316B2 (en) 2011-05-13 2015-01-13 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US9486229B2 (en) 2011-05-13 2016-11-08 Broncus Medical Inc. Methods and devices for excision of tissue
US10434251B2 (en) 2011-08-01 2019-10-08 Alcyone Lifesciences, Inc. Multi-directional microfluidic drug delivery device
US10137244B2 (en) 2011-08-01 2018-11-27 Alcyone Lifesciences, Inc. Microfluidic drug delivery devices with venturi effect
US10272260B2 (en) 2011-11-23 2019-04-30 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US9919129B2 (en) 2012-12-18 2018-03-20 Alcyone Lifesciences, Inc. Systems and methods for reducing or preventing backflow in a delivery system
US10363394B2 (en) 2012-12-18 2019-07-30 Alcyone Lifesciences, Inc. Systems and methods for reducing or preventing backflow in a delivery system
US11213653B2 (en) 2012-12-18 2022-01-04 Alcyone Lifesciences, Inc. Systems and methods for reducing or preventing backflow in a delivery system
US11260201B2 (en) 2012-12-18 2022-03-01 Alcyone Lifesciences, Inc. Systems and methods for reducing or preventing backflow in a delivery system
US10065016B2 (en) 2012-12-18 2018-09-04 Alcyone Lifesciences, Inc. Systems and methods for reducing or preventing backflow in a delivery system
US11602375B2 (en) 2013-06-17 2023-03-14 Alcyone Therapeutics, Inc. Methods and devices for protecting catheter tips and stereotactic fixtures for microcatheters
US10456533B2 (en) 2013-06-17 2019-10-29 Alcyone Lifesciences, Inc. Methods and devices for protecting catheter tips and stereotactic fixtures for microcatheters
US11534592B2 (en) 2013-07-31 2022-12-27 Alcyone Therapeutics, Inc. Systems and methods for drug delivery, treatment, and monitoring
US10441770B2 (en) 2013-07-31 2019-10-15 Alcyone Lifesciences, Inc. Systems and methods for drug delivery, treatment, and monitoring
US10806396B2 (en) 2015-01-26 2020-10-20 Alcyone Lifesciences, Inc. Drug delivery methods with tracer
US10531882B2 (en) 2016-01-04 2020-01-14 Alcyone Lifesciences, Inc. Methods and devices for treating stroke
US10993770B2 (en) 2016-11-11 2021-05-04 Gynesonics, Inc. Controlled treatment of tissue and dynamic interaction with, and comparison of, tissue and/or treatment data
US11419682B2 (en) 2016-11-11 2022-08-23 Gynesonics, Inc. Controlled treatment of tissue and dynamic interaction with, and comparison of, tissue and/or treatment data
US11832877B2 (en) 2017-04-03 2023-12-05 Broncus Medical Inc. Electrosurgical access sheath

Also Published As

Publication number Publication date
US5979453A (en) 1999-11-09

Similar Documents

Publication Publication Date Title
US5979453A (en) Needle myolysis system for uterine fibriods
JP6571217B2 (en) Medical equipment
US9113896B2 (en) Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue
US6238393B1 (en) Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue
EP1932487B1 (en) Electrosurgical system employing multiple electrodes
JP2647557B2 (en) BPH resection method and device
EP0986336B1 (en) System for performing plate type radiofrequency ablation
US6447505B2 (en) Balloon catheter method for intra-urethral radio-frequency urethral enlargement
EP1011495B1 (en) Cool-tip electrode thermosurgery system
EP2706938A1 (en) Radiofrequency ablation catheter device
EP3752084B1 (en) Energy delivery device
JP4871559B2 (en) Cooling RF ablation needle
EP1767165B1 (en) Cooled ablation needle
CA2848436A1 (en) Cooled rf ablation needle
Pawlik et al. Radiofrequency ablation for primary and metastatic liver tumors
Brooks et al. Tissue effects of the vestablate office-based endometrial ablation system
Brooks The vaporizing electrode during resectoscopic surgery
Biggerstaff III A protocol for evaluating abnormal bleeding by fluid-contrast ultrasound

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97518338

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase